176 related articles for article (PubMed ID: 35653801)
1. Silencing of immunoglobulin superfamily containing leucine-rich repeat inhibits gastric cancer cell growth and metastasis by regulating epithelial-mesenchymal transition.
Sun A; Li J; Kong W; Jiang X
Bioengineered; 2022 May; 13(5):13544-13554. PubMed ID: 35653801
[TBL] [Abstract][Full Text] [Related]
2. Silencing of
Zhang P; Li Z; Yang G
Int J Mol Med; 2021 Dec; 48(6):. PubMed ID: 34713300
[TBL] [Abstract][Full Text] [Related]
3. ISLR interacts with MGAT5 to promote the malignant progression of human gastric cancer AGS cells.
Zuo B; Huang Q; Yu W; Xu J
Iran J Basic Med Sci; 2023; 26(8):960-965. PubMed ID: 37427332
[TBL] [Abstract][Full Text] [Related]
4. ISLR affects colon cancer progression by regulating the epithelial-mesenchymal transition signaling pathway.
Chi C; Liu T; Yang S; Wang B; Han W; Li J
Anticancer Drugs; 2022 Jan; 33(1):e670-e679. PubMed ID: 34520435
[TBL] [Abstract][Full Text] [Related]
5. microRNA-33a prevents epithelial-mesenchymal transition, invasion, and metastasis of gastric cancer cells through the Snail/Slug pathway.
Chen DD; Cheng JT; Chandoo A; Sun XW; Zhang L; Lu MD; Sun WJ; Huang YP
Am J Physiol Gastrointest Liver Physiol; 2019 Aug; 317(2):G147-G160. PubMed ID: 30943047
[TBL] [Abstract][Full Text] [Related]
6. F-box and leucine-rich repeat 6 promotes gastric cancer progression
Meng L; Hu YT; Xu AM
World J Gastrointest Oncol; 2023 Mar; 15(3):490-503. PubMed ID: 37009323
[TBL] [Abstract][Full Text] [Related]
7. MTMR2 promotes invasion and metastasis of gastric cancer via inactivating IFNγ/STAT1 signaling.
Jiang L; Liu JY; Shi Y; Tang B; He T; Liu JJ; Fan JY; Wu B; Xu XH; Zhao YL; Qian F; Cui YH; Yu PW
J Exp Clin Cancer Res; 2019 May; 38(1):206. PubMed ID: 31113461
[TBL] [Abstract][Full Text] [Related]
8. LINC00665 promotes cell proliferation, invasion, and metastasis by activating the TGF-β pathway in gastric cancer.
Zhang X; Wu J
Pathol Res Pract; 2021 Aug; 224():153492. PubMed ID: 34091388
[TBL] [Abstract][Full Text] [Related]
9. An Analysis Regarding the Association Between the
Li S; Zhao W; Sun M
Front Genet; 2020; 11():620. PubMed ID: 32612640
[TBL] [Abstract][Full Text] [Related]
10. MiR-675 is frequently overexpressed in gastric cancer and enhances cell proliferation and invasion via targeting a potent anti-tumor gene PITX1.
Liu L; Tian YC; Mao G; Zhang YG; Han L
Cell Signal; 2019 Oct; 62():109352. PubMed ID: 31260797
[TBL] [Abstract][Full Text] [Related]
11. DDR1 enhances invasion and metastasis of gastric cancer via epithelial-mesenchymal transition.
Xie R; Wang X; Qi G; Wu Z; Wei R; Li P; Zhang D
Tumour Biol; 2016 Sep; 37(9):12049-12059. PubMed ID: 27179963
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-34 promotes the proliferation and epithelial-mesenchymal transition of gastric cancer cells.
Li CH; Chen ZM; Chen PF; Meng L; Sui WN; Ying SC; Xu AM; Han WX
World J Gastrointest Oncol; 2022 Oct; 14(10):1968-1980. PubMed ID: 36310707
[TBL] [Abstract][Full Text] [Related]
13. Decreased expression of the long noncoding RNA LINC00261 indicate poor prognosis in gastric cancer and suppress gastric cancer metastasis by affecting the epithelial-mesenchymal transition.
Fan Y; Wang YF; Su HF; Fang N; Zou C; Li WF; Fei ZH
J Hematol Oncol; 2016 Jul; 9(1):57. PubMed ID: 27439973
[TBL] [Abstract][Full Text] [Related]
14. CDC27 Facilitates Gastric Cancer Cell Proliferation, Invasion and Metastasis via Twist-Induced Epithelial-Mesenchymal Transition.
Xin Y; Ning S; Zhang L; Cui M
Cell Physiol Biochem; 2018; 50(2):501-511. PubMed ID: 30308498
[TBL] [Abstract][Full Text] [Related]
15. Block of Proliferation 1 Promotes Proliferation, Invasion and Epithelial Mesenchymal Transformation in Gastric Cancer.
He J; Chen Z; Xue Q; Shi W
Oxid Med Cell Longev; 2022; 2022():2946989. PubMed ID: 35222794
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of miRNA-214 in cancer-associated fibroblasts contributes to migration and invasion of gastric cancer cells through targeting FGF9 and inducing EMT.
Wang R; Sun Y; Yu W; Yan Y; Qiao M; Jiang R; Guan W; Wang L
J Exp Clin Cancer Res; 2019 Jan; 38(1):20. PubMed ID: 30646925
[TBL] [Abstract][Full Text] [Related]
17. Targeting of SPP1 by microRNA-340 inhibits gastric cancer cell epithelial-mesenchymal transition through inhibition of the PI3K/AKT signaling pathway.
Song SZ; Lin S; Liu JN; Zhang MB; Du YT; Zhang DD; Xu WH; Wang HB
J Cell Physiol; 2019 Aug; 234(10):18587-18601. PubMed ID: 30953349
[TBL] [Abstract][Full Text] [Related]
18. CXCR6 predicts poor prognosis in gastric cancer and promotes tumor metastasis through epithelial-mesenchymal transition.
Jin JJ; Dai FX; Long ZW; Cai H; Liu XW; Zhou Y; Hong Q; Dong QZ; Wang YN; Huang H
Oncol Rep; 2017 Jun; 37(6):3279-3286. PubMed ID: 28440473
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of FOXS1 in gastric cancer cell lines inhibits proliferation, metastasis, and epithelial-mesenchymal transition of tumor through downregulating wnt/β-catenin pathway.
Lu Q; Ma X; Li Y; Song W; Zhang L; Shu Y; Wan B
J Cell Biochem; 2019 Mar; 120(3):2897-2907. PubMed ID: 30500980
[TBL] [Abstract][Full Text] [Related]
20. SERPINH1 regulates EMT and gastric cancer metastasis via the Wnt/β-catenin signaling pathway.
Tian S; Peng P; Li J; Deng H; Zhan N; Zeng Z; Dong W
Aging (Albany NY); 2020 Feb; 12(4):3574-3593. PubMed ID: 32091407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
